CAPPELLO JOSEPH (VP, Pharmaceutical Development) sold 0.6% of their position (906.00 shares) of GENELUX CORP on the open market
Open‑market sale worth $2.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/26/2026ACC: 0001493152-26-012971
Officer· VP, Pharmaceutical Development
Since Jan 2023
-906.00
Net shares
Net seller
$2.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
906.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−906.00
Price / share
$2.42
Trade value
$2.19K
% of position
0.6%
3/24/2026
156.06K→155.15K
Total
Net shares
−906.00
Net value
-$2.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/24/2026 | S · Sale | −906.00 | $2.42 | $2.19K | 0.6% | 156.06K | 155.15K |
| Total | −906.00 | -$2.19K | ||||||
Derivative Transactions0
No derivative transactions reported